HIKAL
Back to Balance Sheet
|
HIKAL Last 5 Year Net Current Assets History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Net Current Assets (Including Current Investments) | ₹210 Cr | ₹277 Cr | ₹195 Cr | ₹222 Cr | ₹178 Cr |
What is the latest Net Current Assets ratio of HIKAL ?
Year | Net Current Assets |
---|---|
Mar2024 | ₹210 Cr |
Mar2023 | ₹277 Cr |
Mar2022 | ₹195 Cr |
Mar2021 | ₹222 Cr |
Mar2020 | ₹178 Cr |
How is Net Current Assets of HIKAL Trending?
Years | Net Current Assets | % Change | |
---|---|---|---|
Mar2024 | ₹210 Cr | -24.32 | |
Mar2023 | ₹277 Cr | 42.22 | |
Mar2022 | ₹195 Cr | -12.05 | |
Mar2021 | ₹222 Cr | 24.31 | |
Mar2020 | ₹178 Cr | - |
Compare Net Current Assets of peers of HIKAL
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
HIKAL | ₹3,176.8 Cr | -4.3% | -27% | -21.1% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹391,667.0 Cr | 1.2% | -4.2% | -5.7% | Stock Analytics | |
DIVIS LABORATORIES | ₹163,697.0 Cr | 3% | -9.1% | 31.5% | Stock Analytics | |
CIPLA | ₹126,365.0 Cr | 4.1% | 5.5% | -0.1% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹123,639.0 Cr | 1.1% | 4.3% | 8.2% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹105,479.0 Cr | 3.7% | 0.1% | -7.4% | Stock Analytics |
HIKAL Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
HIKAL | -4.3% |
-27% |
-21.1% |
SENSEX | 1.8% |
-1.7% |
2.9% |
You may also like the below Video Courses